JanOne Inc. SEC Filings

Soul Ventures Holdings Ltd filed a Schedule 13G reporting beneficial ownership of 11,333,200 shares of ALT5 Sigma Corp common stock, equal to 9.2% of the class. The filing states Soul Ventures has sole voting and dispositive power over these shares and that the shares are held by entities subject to its voting control and investment discretion. The statement includes a certification that the position was not acquired to change or influence control of the issuer. The filing identifies the issuer's principal executive office in Las Vegas and provides Soul Ventures’ British Virgin Islands address.

Report summary: Several Citadel entities and Kenneth Griffin jointly report modest, passive holdings of ALT5 Sigma Corporation common stock based on a 122,609,376 share count. Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC each report beneficial ownership of 73,677 shares representing 0.1% of the class. Citadel Securities LLC, Citadel Securities Group LP and Citadel Securities GP LLC each report beneficial ownership of 208,930 shares representing 0.2% of the class. Mr. Kenneth Griffin is reported as beneficially owning 282,607 shares representing 0.2% of the class.

The filing states these holdings are held through Citadel Multi-Strategy Equities Master Fund Ltd. and Citadel Securities and that the reporting persons assert shared voting and dispositive power over the reported shares but no sole voting or sole dispositive power. The filing also clarifies the reporting persons do not claim the holdings were acquired to influence control of the issuer.

Jane Street Group and affiliates report beneficial ownership of ALT5 Sigma Corp common stock totaling 10,061,351 shares, representing 8.2% of the class. The ownership reported is held with shared voting and dispositive power rather than sole control. The filing identifies four related reporting persons—Jane Street Group, LLC; Jane Street Global Trading, LLC; Jane Street Capital, LLC; and Jane Street Options, LLC—with the largest holdings attributed to the Group and Global Trading affiliate. The statement clarifies these positions are not intended to change or influence control of the issuer and lists the issuer's principal executive office.

Schedule 13G filed jointly by ExodusPoint entities and two individuals reports beneficial ownership of shares of ALT5 Sigma Corp common stock. As of August 11, 2025 the Reporting Persons were deemed to beneficially own 6,200,000 shares (about 5.05% of the class) held by ExodusPoint Partners Master Fund, LP; as of the filing date they report they may be deemed to own 5,856,700 shares (about 4.75%). The reporting group has no sole voting or dispositive power and reports shared voting and dispositive power over 5,856,700 shares. The filing includes a Joint Filing Agreement as Exhibit 99.1 and certifications that the holdings are not for purposes of changing control.

JanOne Inc. (JAN) discloses that certain private placement securities (the "PIPE Securities" and Placement Agent Warrant Shares) were issued relying on Section 4(a)(2) and/or Regulation D exemptions and therefore were not registered under the Securities Act or state securities laws. Under a Registration Rights Agreement the company must file a registration statement to permit resale of the PIPE Securities within 15 days of the private placement closing. The company also describes a stockholder approval process for an Amendment and Exchange Cap, with the board recommending approval and an obligation to hold repeat meetings every 90 days until approval is obtained.

Point72 reports a 4.0% common-stock holding in ALT5 Sigma Corp. The filing lists Point72 Asset Management, Point72 Capital Advisors, and Steven A. Cohen as joint filers reporting shared voting and dispositive power over 4,872,756 shares as of the close of business on August 15, 2025. The filers state they directly own no shares and that the shares are held by an investment fund managed by Point72 Asset Management. The filing includes a joint filing agreement and a certification that the stake was not acquired to influence control.

Virland A. Johnson, identified as the issuer's Chief Financial Officer, reported transactions dated 05/30/2025 under the issuer listed as ALT5 Sigma Corp (ALTS). On that date he received 25,000 common shares that vested as Restricted Stock Units under the company's 2024 Equity Incentive Plan at a reported per-share amount of $0.01, leaving him with 38,000 shares beneficially owned after the transaction. He also acquired 125,000 warrants with a conversion/exercise price of $9.31, exercisable on 05/30/2025 and expiring on 05/30/2030, representing the right to purchase 125,000 additional common shares. The Form 4 notes the RSUs vested on the transaction date and lists the holdings as direct beneficial ownership.

ALT5 Sigma Corporation (formerly JanOne Inc., ticker changed to ALTS) reported a sharp increase in fintech revenue alongside larger consolidated losses for the first half of 2025. For the 26 weeks ended June 28, 2025 revenue rose to $11.892 million from $2.169 million a year earlier, and cash and cash equivalents increased to $9.56 million from $7.177 million, reflecting operational receipts and financing activity.

Despite top-line growth, the company recorded a net loss of $11.976 million for the 26 weeks ended June 28, 2025 versus a $1.555 million loss in the prior-year period. Large other losses including a $(3.177) million realized amount on exchange transactions, increased intangible amortization and acquisition-related costs contributed to the wider loss. The company completed two fintech-focused acquisitions: ALT5 Subsidiary (May 2024) and Mswipe (May 9, 2025), with Mswipe purchase consideration fair-valued at $14.2 million and preliminary goodwill of $6.378 million. Digital assets receivable and payable remain material on the balance sheet at roughly $14.4 million and $23.6 million, respectively, and long-term notes payable increased to $21.551 million. The biotechnology operations (Alyea) are presented as discontinued operations.